The Trump administration has temporarily halted work on Medicare rules aimed at lowering drug spending, CNBC reports, including a proposal that would enable Medicare plans to negotiate down prices of drugs in the protected class.
According to the report, the administration also stopped work on a proposal that would ensure Medicare patients received the lowest price on prescriptions at the pharmacy counter.
The Centers for Medicare and Medicaid Services (CMS) announced last week it had received more than 4,000 comments on the pharmacy rule.
“CMS is continuing to carefully review these comments as we continue to consider policies that would lower prescription drug costs, address challenges that independent pharmacies face, and improve the quality of pharmacy care,” CMS said in a statement.
To read the full report on CNBC, click here.